The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...

Read all vaccine information available from your health care professional before receiving the vaccine. If you have any questions, ask your health care professional. This vaccine is given by ...

The World Health Organization (WHO) says that pneumococcal disease is the world’s number 1 vaccine-preventable cause of death among infants and children younger than 5 years of age. These may be ...

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing.

Pneumococcal infections are common in people living with HIV, even with higher CD4 cell counts. Vaccination and HIV treatment reduce the risk of invasive pneumococcal disease. Pneumococcal disease is ...